These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6515706)

  • 1. Evaluation of the fluorescence polarization immunoassay for quantitation of digoxin in serum.
    Al-Fares AM; Mira SA; el-Sayed YM
    Ther Drug Monit; 1984; 6(4):454-7. PubMed ID: 6515706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercomparison of seven radioimmunoassay kits and a fluorescence polarization immunoassay kit for digoxin.
    Erickson KA; Green PJ
    Clin Chem; 1984 Jul; 30(7):1225-7. PubMed ID: 6733904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of protein concentration on the determination of digoxin in serum by fluorescence polarization immunoassay.
    Porter WH; Haver VM; Bush BA
    Clin Chem; 1984 Nov; 30(11):1826-9. PubMed ID: 6207958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
    Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
    Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR; Shank WA; Blouin RA; Clark T
    Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
    Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
    Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
    Spinler SA; Al-Jazairi AS; Cheng JW; Kapoor S; Kobrin S; Shaw L
    Ther Drug Monit; 2000 Dec; 22(6):729-36. PubMed ID: 11128242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
    Ferreri LF; Raisys VA; Opheim KE
    J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
    Molin L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of digoxin Fab antibodies on five digoxin immunoassays.
    Ujhelyi MR; Cummings DM; Green P; Ellison MJ; Vlasses PH
    Ther Drug Monit; 1990 May; 12(3):288-92. PubMed ID: 2349615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Abbott TDx fluorescence polarization immunoassay, Sandoz radioimmunoassay, and high-performance liquid chromatography methods for the assay of serum cyclosporine.
    Schroeder TJ; Pesce AJ; Hassan FM; Wermeling JR; Warner A; Schlueter KT; First MR
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):345-7. PubMed ID: 3284078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of apparent effect of assay methodology on the pharmacokinetics of digoxin.
    Blum RA; DeVito JM; Pleasants RA; Crass RE; Gadsden RH; Leman RB
    Ther Drug Monit; 1987 Dec; 9(4):416-21. PubMed ID: 3424407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of digoxin analysis by EMIT with Immophase and Dac-Cel radioimmunoassay.
    Rumley AG; Trope A; Rowe DJ; Hainsworth IR
    Ann Clin Biochem; 1980 Nov; 17(6):315-8. PubMed ID: 7011165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers.
    Saccoia NC; Hackett LP; Morris RG; Ilett KF
    Ther Drug Monit; 1996 Dec; 18(6):672-7. PubMed ID: 8946664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical evaluation of TDx cyclosporine and metabolites fluorescence polarization immunoassay and comparison with the Cyclo-Trac RIA kit.
    Montojo C; Calvo MV; Domínguez-Gil A
    J Clin Pharm Ther; 1990 Feb; 15(1):45-51. PubMed ID: 2180968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.